[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-AXSM":3,"homepage-market-summary":30,"stock-news-AXSM":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"AXSM","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Axsome Therapeutics, Inc","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.","925","New York, NY",false,{"close":16,"open":17,"high":17,"low":18,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},179.25,182.55,175.455,182.07,-2.82,-1.55,981118.965823,20685,178.9817,260.19,117.3,699788.1051051792,43.4,2732,{"status":31,"indices":32,"watchlist":76,"sectors":98,"benchmarks":154},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":14,"sparkline":75,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":39,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":39,"sparkline":90,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":39,"sparkline":97,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[99,104,109,114,119,124,129,134,139,144,149],{"name":100,"etf":101,"change":102,"price":103,"is_up":39},"Technology","XLK",1.01,199.81,{"name":105,"etf":106,"change":107,"price":108,"is_up":39},"Financials","XLF",0.06,53.49,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":39},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":132,"price":133,"is_up":39},"Industrials","XLI",0.78,169.95,{"name":135,"etf":136,"change":137,"price":138,"is_up":39},"Materials","XLB",0.66,48.86,{"name":140,"etf":141,"change":142,"price":143,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":39},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":89,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},17,[175,181,187,193,199,205,211,217,223,229,234,239,245,251,256,261,266],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"Axsome Therapeutics, Inc. (AXSM) Stock Price, News, Quote & History - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiTkFVX3lxTFBsV0NHamJ1WHB4NnJkaUtvd0VacUh3bWFJR3A3RHNqVldhbldOUzA3Q0h3MUg1WmhPU1h2LU0tQXZPZ3pGOE1oLU1QdVVTUQ?oc=5","Sat, 03 Oct 2026 10:30:19 GMT","Axsome Therapeutics, Inc. (AXSM) Stock Price, News, Quote & History Yahoo Finance","Yahoo Finance",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Axsome Therapeutics (NasdaqGM:AXSM) Stock Forecast & Analyst Predictions - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimgFBVV95cUxNSW1adlc3bnRteXVIWHNySW00ekhZc1U1TW84aWlkMFR0UTNSd1A5LXp4cnVNdmFfekFuTWpIVFRVM0YwYm9ySWNCVU05Ym5BVk1xMDBxQ3JUNzVGak5IVTVvMFRYdG1vZXdaZnFNRGhpSXJpMW5TR2t5Y2l1VEVQT19FOS1Vc1h0aTNKZjBVTDE1QWVxb2VKbU53?oc=5","Mon, 28 Sep 2026 07:00:00 GMT","Axsome Therapeutics (NasdaqGM:AXSM) Stock Forecast & Analyst Predictions Simply Wall Street","Simply Wall Street",{"title":188,"link":189,"pubDate":190,"description":191,"source":192},"Axsome Therapeutics, Inc. (AXSM) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTE9hemhGek1JOFJvX05hZk5MQjhWRjdhR1JfZEFkVHpxWEZ3ODRVR3B4OTc0aksxUGFZYm4wTHhudjU1QWM4ODRNb181c3ptMEdPY1E?oc=5","Thu, 01 Oct 2026 03:53:52 GMT","Axsome Therapeutics, Inc. (AXSM) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":194,"link":195,"pubDate":196,"description":197,"source":198},"Axsome Therapeutics slides as investors weigh launch execution and policy risks - quiverquant.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMisgFBVV95cUxQSTExNjdKY2c3UTZWV2EzZlZ1OUNhVHpGMzhlTFB6cFlZSUltRkV3djJuaGdPUUFjZGg3RllkSkhnel9tYkRvWl9fNnI4S2ctYUFRVkRUS29TWjhxNzVocEN5X3hMLU1zT0gzZHk1cUd1Tks4eHNfWVVyemFTTm9yWXR0TlRXLVlWMnNMQ2E2VGhNNzhxN0RtRGNGNWtZajZWWnk4RHVMemkwNjBaU2xvMnJn?oc=5","Tue, 29 Sep 2026 17:38:00 GMT","Axsome Therapeutics slides as investors weigh launch execution and policy risks quiverquant.com","quiverquant.com",{"title":200,"link":201,"pubDate":202,"description":203,"source":204},"Three in four caregivers wish they had recognized Alzheimer’s agitation sooner - stocktitan.net","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxQOXRZUVJFWHJjWjFkNExtVUFzSUNkTExKSks4WjdVOEhNOFhaLVFOa21RS1JDejRNbTNnVTA0Z05xNThpUHU2Y3VWTkVPUjlyN2NVVHlNbURvUVU5M2dSNmpBajlHbndCalRGaXJpSDl3ZWJ4STNfUDEwME80S3pUMTZYTVFjNl9JTFF0LUh3UUlRUU9QSHNSazBfVTZsYjU4QU1jMlBoR0NjS3ZoYXZlNzEtVWtpYVVIOUNpaWU3dw?oc=5","Mon, 21 Sep 2026 11:00:00 GMT","Three in four caregivers wish they had recognized Alzheimer’s agitation sooner stocktitan.net","stocktitan.net",{"title":206,"link":207,"pubDate":208,"description":209,"source":210},"Axsome Therapeutics (NASDAQ:AXSM) Shares Down 5.4% on Analyst Downgrade - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxOSE1kOGNwSEt3WVVyT0F5TnR4Q2tMR0ZuOHYtbWRqdkRvMGNfemJmYlRNNVM3bjA3UVFCbWZSU3hoc21RSC1qTUVJOWo2MFpqb1JHclpteWNZZElOOG9kNmtNbzNRbEh5ZG5JNksxb1ZZMW14WHJoTTJwZHY2bHBCQXU1VnZGWXJleGVBTUkzRnloNlh6R01nYUx6anZhUVBwZHVOcUZMa2FDakFIWG03a210a0tyeGhFQ0k5N3RjeGRaejBhcmc?oc=5","Tue, 29 Sep 2026 17:43:52 GMT","Axsome Therapeutics (NASDAQ:AXSM) Shares Down 5.4% on Analyst Downgrade MarketBeat","MarketBeat",{"title":212,"link":213,"pubDate":214,"description":215,"source":216},"Responsive Playbooks and the AXSM Inflection - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxQSHZGTmtfWlBnaWhzbE1ncUZScE1laUxSY1ZvSENROFZLWTYtOVMwR2JjNlpDemFBdE5xUHRpTVRWdnZsNHBGMTZFRUxIV0dUSTN1SEpFYWh0aTc1dUs1TUZMbmgxaFMxdHRtc3ZxeWVyeVl3bTl2OUpoWXlqaDdjOUF4Q3o1eElmMWtMdW5RRl8wMGdpcGcwQzBVV1IwSFE4VzBVMWxKY2JxaGV6UHBWOWcxRlZEaVY3WmtvdWRjNklRV1k?oc=5","Wed, 30 Sep 2026 08:22:01 GMT","Responsive Playbooks and the AXSM Inflection Stock Traders Daily","Stock Traders Daily",{"title":218,"link":219,"pubDate":220,"description":221,"source":222},"AXSM Maintains Rating by Morgan Stanley -- Price Target Lowered to $247 - GuruFocus","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgFBVV95cUxQYWtfUVBmRE9SdzFDU0k0YkRMVTdyNkg4NWFWRWRVUHRCLWw4VThYQzlQVW1DLW94d1NJdnlWeFlBWk5kbnlqM0g4WXFmOUwzdFlCMnNRUlF3OFJRclZSenh6S0VTZzZRTXI2ajY2eXNWMnI3VktOdm9KSDAyZzBHMFhQRmNGeE1NOVNQdHdCYjF5bmJ3ODNHNHFUUzdJWC1IZ0tVdkhfTm9Hdw?oc=5","Fri, 25 Sep 2026 17:53:45 GMT","AXSM Maintains Rating by Morgan Stanley -- Price Target Lowered to $247 GuruFocus","GuruFocus",{"title":224,"link":225,"pubDate":226,"description":227,"source":228},"Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Axsome Therapeutics (AXSM) - The Globe and Mail","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiqgJBVV95cUxNa1RQczZSb191Yl90QTc5M2EwbmNPYkJDX1NCc2tuOGJTd0dLWGFmaWp1MWhuNWdKc01MOElxYlFaZ3RyTXZ1UzduY1lKOFZrbGlIejNkUWgxS1dTenR2VVowYVBnblNKSVdqZVpXTkN1cm9uc2NxaDF6ZTVEWHRpNlZLMzRRRWxSZlRROFJibWRtcVBqZmFTRnhpMjFuT291NTdOeHVUMTZ0OENaZnk4Z29pSElHbVBZSnZhWGk4ZHhLXzBnYkc5NS1uZ1FkdmJpaV9hMHhPYU1RaS12REp6dEVSOEJXR2hMejRuRUlBMDF0aDJJNHh2MktWQ0ZQMlRDR2NJQVB3dnJST0FPc050Y1Q2dW1JdDkwZVMyMWhCaWNLOG53bGdMVFB3?oc=5","Wed, 30 Sep 2026 13:44:00 GMT","Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), ClearPoint Neuro (CLPT) and Axsome Therapeutics (AXSM) The Globe and Mail","The Globe and Mail",{"title":230,"link":231,"pubDate":232,"description":233,"source":186},"Can Axsome Therapeutics (AXSM) Keep Justifying Its Price On Sales? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 30 Sep 2026 10:34:25 GMT","Can Axsome Therapeutics (AXSM) Keep Justifying Its Price On Sales? Simply Wall Street",{"title":235,"link":236,"pubDate":237,"description":238,"source":210},"Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Rating of \"Moderate Buy\" from Brokerages - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi6wFBVV95cUxPMWEtVTFsYVdvMFY4bUlwNC1iYnNjakw0Z0EyTko5YlVWRFU2Z3JFNkVKQUREWFZ5enhUb21QR2RZYUNrcTl0d1REOXhlZk9FYUFOVmlOSC1VZUxVclhqTFcycV9CUzJ0Nkc2dUhBRHpLYkF3X3NNV3VDMnhOUF9fZEhud1RfSXA4UGNLOFllZ2R4UkNlanVCMjJlRnJZanpQQ0VvR1AxZjRFMU5HZ0hRRWdKLS1sMWN6X2paYkp0U1hRUEo5OXcxYXJ0WWthbGphVUhYTlREdDllajRic3FSdjVFZEtFR1NuRVhn?oc=5","Fri, 02 Oct 2026 06:32:05 GMT","Axsome Therapeutics, Inc. (NASDAQ:AXSM) Receives Average Rating of \"Moderate Buy\" from Brokerages MarketBeat",{"title":240,"link":241,"pubDate":242,"description":243,"source":244},"H.C. Wainwright reiterates Axsome stock Buy rating at $290 target By Investing.com - Investing.com India","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwAFBVV95cUxNbDlBVE1KNUtHbURhZFZuNWlMRFVOb24wRm05aGVBd0dtS1Z1UzNzVXJJdXBZaFlXZEpoanJsQ0QxSzh5R3VtY3pIdmEya2pfRktNU1pvWjluNXVTU3ZGcHJ1NnR4Mk9sc0xsMUN3bVV5dlBtRXlaWWpuUk5aSnA1RGpyQ2FaMGdBWkdFck5MRk9sOEVCQWtJWXB1VUxsSFNSbzZUXzNIcVYxbUlhN1JaS1Nza2tXNlFSN3YtQTlZMFM?oc=5","Fri, 25 Sep 2026 11:45:29 GMT","H.C. Wainwright reiterates Axsome stock Buy rating at $290 target By Investing.com Investing.com India","Investing.com India",{"title":246,"link":247,"pubDate":248,"description":249,"source":250},"AXSM Q2 2026 Earnings: Wider-Than-Expected Loss per Share Meets a Modestly Positive Stock Reaction - Management Guidance Update - dars.gov.et","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0wFBVV95cUxON3VVY21zajJzMkstZWFjaDVHWFkwSDQtNVNIcDh6Qko4RzFtejd6M3c0MmJtRWRib29xTXZzcnNETm14X2FCT0liX2pHYUp0OWUtOC1YN2IzMzRqYmFSYjI5cUNEZTJsZEpKVXNvVnJqNF84dEFjWHpKSVZvRlRjNFJiOVFJejVfVG11cjFkc2xWT0pxV2ctbTd4YllPNWd1RlUzd1VzNFo5LXptMHNQM1dZOHV0bnJhUmVaa2hycG9DSmY4ZUlzNEFvU2ZmUWUtZTRB?oc=5","Tue, 22 Sep 2026 13:48:30 GMT","AXSM Q2 2026 Earnings: Wider-Than-Expected Loss per Share Meets a Modestly Positive Stock Reaction - Management Guidance Update dars.gov.et","dars.gov.et",{"title":252,"link":253,"pubDate":254,"description":255,"source":180},"Truist Raises Price Target on Axsome Therapeutics to $285 From $200, Keeps Buy Rating - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMinwFBVV95cUxOYXNvYW1rbkxCZFl3MnBZc1dtNVdzcHNNT0dxSnZTX1BxUnlJaEtJVWdnSHFlb1p1ZTBNMHllMHUyUXNpUXNEYWxfajJSMTM2SmxqdmZDd3RrdlUzbThLRENzMVlKRF9kNGVlNnphVndTRkU5QTUtcDcwdHNlTnlSd0ttV3M1dlZsS0p4MFM3UXhZYjUyY0otWW5fRHh4Rkk?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","Truist Raises Price Target on Axsome Therapeutics to $285 From $200, Keeps Buy Rating Yahoo Finance",{"title":257,"link":258,"pubDate":259,"description":260,"source":210},"Axsome Therapeutics (NASDAQ:AXSM) Price Target Cut to $267.00 by Analysts at Deutsche Bank Aktiengesellschaft - MarketBeat","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi-wFBVV95cUxOWXJHb0pZUk9UY1Q5ZHR3c3BQVVNhNzZHT1JtR3VmQWl1U0pFbXNsejFoQlRIUndjUnhoTmpUTERMUjM1aUx3TFF4bUFjSEh0eXJ0dnFFS1ZEaWsyTkE2SzZvVjFHRlc0R0ZENEhLRldnSFBLbTdZZmhidW9XNFE3Sllfb2ZPU2MzRkhFY3JVbVpkMHJFM3Nybi10VWFtdDFCOEdoZzVwVmtxRHVwbldlX2NHMDFDbFdTZFc5S0UxYUVoN0xCN0ZCQVRlZjBFUC01c2ZFdVI0VVAwLVRlR0pjQVdBaHRBNEY2azYyeGtwZm1Xd0Y0UEdHc0I5dw?oc=5","Tue, 29 Sep 2026 14:43:18 GMT","Axsome Therapeutics (NASDAQ:AXSM) Price Target Cut to $267.00 by Analysts at Deutsche Bank Aktiengesellschaft MarketBeat",{"title":262,"link":263,"pubDate":264,"description":265,"source":186},"Is Axsome Therapeutics (AXSM) Undervalued As Caregiver Survey Data Tests Its CNS Growth Story? - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Sun, 27 Sep 2026 18:32:31 GMT","Is Axsome Therapeutics (AXSM) Undervalued As Caregiver Survey Data Tests Its CNS Growth Story? Simply Wall Street",{"title":267,"link":268,"pubDate":269,"description":270,"source":271},"AXSM270521P00110000 interactive stock chart | AXSM May 2027 110.000 put stock - Yahoo Finance UK","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiZEFVX3lxTE9OM3FqTmY2bjhiV3I1aURtNmRDeEExN0NwcUliMTB0SlpFOWJFaG1JeWpfc3BxcDBUNUc1SUhvYkdrRnU3YXBSSHVIRlhQTWpXOXlxWjR5RzBlajRVN1d5WUwtZmk?oc=5","Thu, 01 Oct 2026 14:34:05 GMT","AXSM270521P00110000 interactive stock chart | AXSM May 2027 110.000 put stock Yahoo Finance UK","Yahoo Finance UK"]